Well we don't know what the results will bring, but while we wait for the third cohort to reach 52 weeks, the first two cohorts also extend their trial data.
One thing we do know is that OPF is progressing with the approvals for Diabecell. I did think they would announce FDA approval, but perhaps the first we will know is that they have registered the trial protocol. You have to think that would be likely sometime in teh next 3 months.
What can we expect in May?, page-21
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
